OR11-3 Steroid Treatment in the Management of Destructive Thyrotoxicosis Induced by PD1 Blockade

BACKGROUND: Destructive thyroiditis is the most common endocrine immune related adverse event (iRAEs) in patients treated with anti-PD1/PD-L1 agents. Given its self-limited course, current guidelines recommend no treatment for this iRAE. Nevertheless in patients with enlarged thyroid volume and a po...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonangeli, Lucia, Antonuzzo, Andrea, Brogioni, Sandra, Chella, Antonio, Cremolini, Chiara, Latrofa, Francesco, Lupi, Isabella, Marcocci, Claudio, Montanelli, Lucia, Pierotti, Laura, Santini, Ferruccio, Sardella, Chiara, Sgrò, Daniele, Viola, Nicola, Brancatella, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627186/
http://dx.doi.org/10.1210/jendso/bvac150.1653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627186/
http://dx.doi.org/10.1210/jendso/bvac150.1653

Ejemplares similares